These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30958326)

  • 1. WITHDRAWN: Performance of survivin mRNA as a biomarker for breast cancer among Vietnamese women.
    Nguyen HM; Dao MQ; La HT
    Breast Dis; 2019 Mar; ():. PubMed ID: 30958326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of
    Nguyen HM; Dao MQ; La HT
    Heliyon; 2019 Mar; 5(3):e01371. PubMed ID: 30957048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WITHDRAWN: LncRNA TUG1 promotes breast cancer cell proliferation via inhibiting miR-9.
    Zhao XB; Ren GS
    Cancer Biomark; 2016 Oct; ():. PubMed ID: 27791993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Downregulation of MicroRNA-152 and Inhibition of Cell Proliferation, Migration, and Invasion in Breast Cancer.
    Maimaitiming A; Wusiman A; Aimudula A; Tudahong T; Aisimutula D
    Oncol Res; 2017 Jun; ():. PubMed ID: 28653610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WITHDRAWN: Serum miR-106b upregulation predicts poor prognosis in patients with colorectal cancer.
    Zhao Y; Ren Q; Zhu K
    Cancer Biomark; 2018 May; ():. PubMed ID: 29865041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WITHDRAWN: BRCA1 protein expression and TOP2A gene aberration and protein expression in four molecular subtypes of breast cancer.
    Mitrović O; Mićić M; Cokić V; Koko V; Dikić D; Budeč M; Vignjević S; Subotički T; Jovčić G
    Pol Arch Med Wewn; 2013 Jun; ():. PubMed ID: 23778266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Results of the Two-County trial of mammography screening are not compatible with contemporaneous official Swedish breast cancer statistics.
    Zahl PH; Gøtzsche PC; Andersen JM; Mæhlen J
    Eur J Cancer; 2006 Mar; ():. PubMed ID: 16530407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human mammaglobin mRNA in breast cancer cells among Vietnamese women.
    Nguyen HM; Dao MQ
    Breast Cancer (Dove Med Press); 2019; 11():143-150. PubMed ID: 30936743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: The safety of synthetic paclitaxel by intralesional delivery with OncoGeltrade mark into skin breast cancer metastases: method and results of a clinical pilot trial.
    Rohr UD; Oberhoff C; Markmann S; Gerber B; Scheulen M; Schindler AE
    Arch Gynecol Obstet; 2005 Nov; ():. PubMed ID: 16315026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Serum miRNA-203 expression, a potential biomarker for recurrence and prognosis in papillary thyroid carcinoma.
    Zheng J; Li J
    Cancer Biomark; 2016 Sep; ():. PubMed ID: 27689614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: CXCR4 promotes growth and sphere formation of hypoxic breast cancer side 7 population cells via activation of c-Jun/ABCG2 pathway.
    Liu H; Shi B; Yan Y; Niu L; Zhou Y; Cai H; Ge G
    Oncol Res; 2016 Sep; ():. PubMed ID: 27697100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WITHDRAWN:Primary Rhabdomyosarcoma of the Breast: A Report of Two Cases and Literature Review.
    Shin J; Kim HJ; Kim DY; Gong G; Cho KJ
    J Pathol Transl Med; 2018 Oct; ():. PubMed ID: 30286562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of urine-based survivin mRNA test using reverse transcription-polymerase chain reaction for bladder cancer: a systematic review.
    Xia Y; Liu YL; Yang KH; Chen W
    Chin J Cancer; 2010 Apr; 29(4):441-6. PubMed ID: 20346223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal expression of survivin and SMAC/DIABLO in primary breast cancer.
    Mansour A; Nabil M; Ali-Labib R; Said H; Annos F
    Med Oncol; 2012 Dec; 29(4):2535-42. PubMed ID: 22161156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WITHDRAWN: Characterization of heterogeneity of hypoxia with 18FMISO PET/CT, BOLD fMRI and immunohistochemistry in human breast tumor xenograft: initial study.
    Cheng J; Zhang J; He S; Qi M; Zhang Y; Zhu X; Zhang Y; Zhang J; Geng D
    Q J Nucl Med Mol Imaging; 2020 Apr; ():. PubMed ID: 32286767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WITHDRAWN: MicroRNA-18a promotes proliferation and metastasis in oral squamous cell carcinoma via targeting KLF4.
    Hou D; Fang T; Song L; Sun B; Liu B; Chen L
    Cancer Biomark; 2018 Dec; ():. PubMed ID: 30614801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic landscape and personalized tracking of tumor mutations in Vietnamese women with breast cancer.
    Nguyen Hoang VA; Nguyen ST; Nguyen TV; Pham TH; Doan PL; Nguyen Thi NT; Nguyen ML; Dinh TC; Pham DH; Nguyen NM; Nguyen DS; Nguyen DQ; Lu YT; Do TTT; Truong DK; Phan MD; Nguyen HN; Giang H; Tu LN
    Mol Oncol; 2023 Apr; 17(4):598-610. PubMed ID: 36495126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer.
    Zohny SF; El-Shinawi M
    Med Oncol; 2011 Dec; 28 Suppl 1():S108-14. PubMed ID: 20978950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.